ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 220 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $521 | -22.8% | 14,623 | 0.0% | 0.00% | -25.0% |
Q2 2023 | $675 | -4.5% | 14,623 | -17.0% | 0.00% | 0.0% |
Q1 2023 | $707 | +24.9% | 17,623 | +44.2% | 0.00% | 0.0% |
Q4 2022 | $566 | -99.9% | 12,223 | +16.2% | 0.00% | +33.3% |
Q3 2022 | $436,000 | -30.6% | 10,523 | 0.0% | 0.00% | -25.0% |
Q2 2022 | $628,000 | -17.8% | 10,523 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $764,000 | -13.7% | 10,523 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $885,000 | -6.7% | 10,523 | 0.0% | 0.00% | -20.0% |
Q3 2021 | $949,000 | -5.4% | 10,523 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $1,003,000 | -20.8% | 10,523 | -5.4% | 0.01% | -28.6% |
Q1 2021 | $1,266,000 | -8.7% | 11,123 | +11.0% | 0.01% | -12.5% |
Q4 2020 | $1,387,000 | +68.3% | 10,023 | 0.0% | 0.01% | +33.3% |
Q3 2020 | $824,000 | -38.9% | 10,023 | -41.9% | 0.01% | 0.0% |
Q2 2020 | $1,348,000 | +137.3% | 17,246 | +115.6% | 0.01% | -64.7% |
Q3 2016 | $568,000 | +45.3% | 8,000 | 0.0% | 0.02% | +6.2% |
Q2 2016 | $391,000 | -22.7% | 8,000 | 0.0% | 0.02% | -27.3% |
Q1 2016 | $506,000 | -71.8% | 8,000 | -50.0% | 0.02% | -37.1% |
Q4 2015 | $1,795,000 | – | 16,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 38,100 | $2,928,000 | 1.67% |
Opaleye Management Inc. | 80,000 | $6,149,000 | 1.59% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 410,000 | $31,517,000 | 1.06% |
Opus Point Partners Management, LLC | 6,311 | $485,000 | 1.05% |
SECTOR GAMMA AS | 68,015 | $5,228,000 | 0.87% |
Capital Impact Advisors, LLC | 27,074 | $2,061,000 | 0.76% |
FORTALEZA ASSET MANAGEMENT INC/ | 1,130 | $87,000 | 0.71% |
CAPITAL INTERNATIONAL LTD /CA/ | 46,957 | $3,610,000 | 0.63% |
Virtus ETF Advisers LLC | 8,794 | $676,000 | 0.60% |
Rock Springs Capital Management LP | 200,000 | $15,374,000 | 0.59% |